Simultaneous Isolation of Hormone Receptor Positive Breast Cancer Organoids and Fibroblasts Reveals Stroma-Mediated Resistance Mechanisms

The authors presented an optimized protocol that allows high take-rate, and simultaneous propagation of patient-derived organoids and matching cancer-associated fibroblasts, from primary and metastatic hormone receptor-positive breast cancers.